Home » The Clear Picture – Practical Guides » Andropause and bone health
Understanding testosterone deficiency in men.
Andropause is often described as the male menopause, but men do not experience the same sudden hormonal change that women experience at menopause. This guide explains what the term really means, how possible testosterone deficiency is assessed, and why persistently low sex-hormone levels can affect bones, muscles and fracture risk.
Not in the usual sense. Testosterone levels can fall gradually as men grow older, but there is no single age at which every man’s testosterone suddenly drops. Men do not all develop symptoms, and there is no universal end to fertility.
The word andropause is therefore a convenient public term rather than a precise description. When a man has relevant symptoms together with repeatedly low testosterone levels, the more accurate terms are testosterone deficiency, male hypogonadism or, when it develops later in life, late-onset hypogonadism.
The symptoms are real, but testosterone is only one possible explanation. Poor sleep, stress, depression, obesity, diabetes, vascular disease, medicines and other health conditions can produce a very similar picture.
Symptoms raise the question, but symptoms alone do not confirm testosterone deficiency. Proper assessment requires the symptoms and reliable blood-test evidence to be considered together.
Testosterone is produced mainly in the testes under signals from the brain and pituitary gland. It is important throughout adult life, not only for sexual function. It contributes to sperm production, red-blood-cell production, muscle mass, physical strength, body-fat distribution, mood and the maintenance of bone.
Some testosterone acts directly. Some is converted into oestradiol, a form of oestrogen. Men need both androgen and oestrogen activity for healthy bone remodelling. Oestrogen is not exclusively a female hormone, just as testosterone is not exclusively a male hormone.
Sexual changes tend to be more closely linked with testosterone deficiency than general symptoms such as tiredness. Possible features include:
Erectile difficulty does not automatically mean low testosterone. Blood-vessel disease, diabetes, medicines, smoking, anxiety and relationship factors are common causes. Because erectile difficulty can sometimes be an early sign of cardiovascular disease, it deserves a proper health review rather than being dismissed as ageing.
A man may also notice:
These symptoms are not specific. Their pattern, severity, duration and effect on daily life matter more than simply counting how many are present.
Middle and later life often bring changes that affect energy, sleep, mood, sexual function and body composition. Possible contributors include:
Some of these factors lower testosterone. Others cause similar symptoms without true testosterone deficiency. More than one factor may be present at the same time.
Bone is living tissue. Old or damaged bone is continually removed and replaced. This process is called bone remodelling. Testosterone and oestradiol help keep removal and replacement in balance.
Oestradiol helps restrain excessive bone breakdown. A proportion of a man’s testosterone is converted into oestradiol inside the body.
Testosterone also acts through androgen receptors and supports bone formation, bone size and the maintenance of the skeleton.
Testosterone helps preserve muscle mass and strength. Strong muscles place useful mechanical loads on bone and help support balance and mobility. Better strength and function may reduce the likelihood of some falls. Hormone deficiency can therefore affect fracture risk through both the bone and the person around the bone.
When testosterone is markedly or persistently low, oestradiol levels may also become too low. Bone breakdown can then outpace bone replacement. Over time, bone density may fall and the internal structure of bone may become less robust.
At the same time, loss of muscle and strength can reduce the healthy loading that bones receive. Reduced activity, poorer balance and frailty may increase the chance of falling. The result is not one simple pathway: bone strength, muscle strength and falls can all be affected.
No. A mildly low or borderline result does not prove that a man’s bones are weak, and not every man with testosterone deficiency develops osteoporosis. The duration and severity of the deficiency matter, as do age, genetics, nutrition, activity, smoking, alcohol, medicines, illness and previous fractures.
However, established hypogonadism is a recognised secondary cause of osteoporosis in men. It becomes particularly relevant when a man is younger than expected for low bone density, has sustained a fragility fracture, has lost height, or has other features of hormone deficiency.
A testosterone result cannot measure bone strength. Equally, a bone-density result cannot show whether testosterone is low. Each assessment answers a different question.
Androgen deprivation therapy for prostate cancer deliberately lowers testosterone or blocks its action. This can produce a much larger and faster hormonal change than ordinary ageing. Bone loss and fracture risk can increase, particularly when therapy continues for a long time.
Men starting or receiving androgen deprivation therapy should have bone and fracture risk considered as part of their wider support. They may need a bone-density assessment, attention to calcium and vitamin D, suitable exercise and, when risk is high, a specific bone-protective medicine. Testosterone replacement is not normally appropriate when testosterone is being suppressed as part of prostate cancer management.
Usually not. Low bone density often causes no pain or warning signs. A vertebral fracture may sometimes be silent, or it may present as sudden back pain, height loss or an increasingly rounded upper back. For some men, the first clear sign is a fracture.
Testing is most useful when there are persistent symptoms or signs that could reasonably reflect testosterone deficiency. It may also be considered when a man has unexplained low bone density, a fragility fracture, unexplained anaemia, infertility, very small testes, pituitary disease or a history of treatment that could affect the testes or pituitary gland.
Routine testing of every middle-aged man without symptoms is not generally recommended. The aim is to investigate a meaningful health question, not to search for an age-related number in isolation.
Testosterone changes during the day and is usually highest in the morning. It can also fall temporarily after poor sleep, a meal, acute illness, heavy physical stress or certain medicines. Laboratory methods and reference ranges are not identical.
Confirmation therefore normally requires at least two separate early-morning blood tests, preferably while fasting and when the man is otherwise well. For shift workers, timing may need to reflect the normal sleep-wake pattern. A result taken during acute illness may need to be repeated after recovery.
Most testosterone travels in the blood attached to proteins, especially sex hormone-binding globulin, known as SHBG, and albumin. Total testosterone measures the attached and unattached hormone together. Free testosterone refers to the small portion that is not tightly bound and is more readily available to tissues.
Changes in SHBG can make total testosterone harder to interpret. Obesity and insulin resistance may lower SHBG, while ageing, thyroid or liver conditions and some medicines may raise it. When the total result is borderline or SHBG may be unusual, SHBG and a calculated free-testosterone result can add useful context.
No sound conclusion can be reached from a number alone. Symptoms, repeat results, the laboratory’s method and reference range, SHBG and the man’s wider health all matter.
Further tests help explain why testosterone is low and whether another condition is contributing. These may include:
A clinician may consider bone-density and fracture-risk assessment when testosterone deficiency is marked or prolonged, or when other bone-health concerns are present. Important reasons include:
DXA is the established clinical method for measuring bone mineral density. REMS is an ultrasound-based assessment that can also provide bone-density information and, where available, additional fragility information. The choice depends on the clinical question, local pathway and the individual. Neither assessment should be interpreted in isolation from fractures, falls, medicines, health history and other risk factors.
The first step is to understand why testosterone is low. Addressing obstructive sleep apnoea, improving diabetes control, reviewing an opioid or corticosteroid prescription, correcting undernutrition, or addressing a pituitary or testicular condition may be more important than focusing only on the testosterone number.
In men carrying excess weight, testosterone may improve with sustainable weight reduction and better metabolic health. This does not mean symptoms should be blamed on weight; it means that body composition and hormones influence one another and deserve respectful, practical support.
These measures do not guarantee that testosterone will normalise, and they do not replace other options when fracture risk is high. They support the wider system in which hormones, muscles and bones function.
Testosterone replacement therapy may be considered when a man has consistent symptoms, repeatedly low levels and an assessed cause for the deficiency. It should not be prescribed simply as an anti-ageing tonic or in response to one borderline result.
Depending on the individual, replacement may improve sexual desire, some aspects of sexual function, anaemia, lean body mass and wellbeing. The response is variable. Erectile difficulties caused mainly by vascular disease, diabetes or psychological factors may not resolve with testosterone alone.
In men with genuine testosterone deficiency, replacement can increase bone mineral density, particularly at the spine, and may improve estimates of bone strength. These changes usually take time and are not a reason to judge progress after only a few weeks.
However, an improvement in bone density is not the same as proof that fewer fractures will occur. Large clinical research has not shown that testosterone replacement can be relied upon to prevent fractures. A man with osteoporosis or high fracture risk may still need a separate bone-protection plan even when his testosterone deficiency is being addressed.
Testosterone replacement corrects an established hormone deficiency. It is not a substitute for a full fracture-risk assessment or for bone-specific support when that is indicated.
The potential benefits and disadvantages should be discussed individually. Important considerations include fertility wishes, prostate and breast history, blood count, cardiovascular health, sleep apnoea and urinary symptoms. Monitoring commonly includes symptoms, testosterone level, full blood count and age-appropriate prostate assessment.
Possible unwanted effects include acne or oily skin, breast tenderness, fluid retention and an excessive rise in red blood cells. Testosterone replacement can reduce sperm production and may shrink the testes. It should not be started without proper assessment, and non-prescribed testosterone or anabolic steroids carry additional risks.
Testosterone taken from outside the body can switch down the pituitary signals that drive sperm production. A man may feel better while his sperm count falls substantially. Anyone who wants to conceive now or in the future should say so before starting replacement, because other specialist approaches may be more appropriate.
These examples show why the whole pattern matters:
A routine appointment is appropriate for persistent sexual, physical or emotional symptoms. More urgent advice is needed for sudden severe headache with visual disturbance, a new testicular lump, severe testicular pain, a suspected fracture, new severe back pain with weakness or altered bladder or bowel control, or thoughts of self-harm.
Andropause is not an inevitable male menopause. The useful question is whether a man has symptoms together with persistent, properly confirmed testosterone deficiency. When he does, the assessment should look beyond sexual symptoms to muscle, metabolic health, fertility and bone, while remembering that no single hormone or scan result tells the whole story.
Produced for educational purposes by the Education Directorate of IIMHE. This guide supports discussion and does not replace individual clinical advice. IIMHE · The Clear Picture · Practical Guides · September 2026.
2nd February 2026 @ 20:00 GMT
Nutrition and musculoskeletal health
Given by: Dr Kimberley Zambito, Orthopaedic Consultant
Hosted by: Dr Nick Birch
Throughout 2026 and beyond, IIMHE (the International Institute of Musculoskeletal Health Education), in partnership with OsteoscanUK, will host a series of engaging educational webinars, open to anyone interested in bone and musculoskeletal health.